News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Outcomes in patients with oligoprogression following 1st line IO or ChemoIO
Photo from docwirenews.com
Oct 7, 2024, 16:46

Outcomes in patients with oligoprogression following 1st line IO or ChemoIO

Gerry Hanna, Radiation Oncologist at St James’s Hospital, shared a post on X:

“Very intresting paper by Lauren Julia Brown, Harriet Gee, Eric Hau from Australia. They report outcomes in patients with oligoprogression following 1st line IO or ChemoIO.
Patients who receive radiotherapy have better survival.
Paper link on JTO & JTO CRR.”

Radiotherapy Improves Survival in NSCLC After Oligoprogression on Immunotherapy: A Cohort Study

Authors: Lauren Julia Brown, et al.

Outcomes in patients with oligoprogression following 1st line IO or ChemoIO

 

Outcomes in patients with oligoprogression following 1st line IO or ChemoIO

Source: Gerry Hanna/X

cancer cancer awareness cancer care Dublin Eric Hau fight against cancer Gerry Hanna Global fight against cancer Harriet Gee JTO & JTO CRR Lauren Julia Brown NSCLC OncoDaily Oncology radiotherapy St James's Hospital
Special Coverage
Insight
Oct 7, 2024, 16:46
Outcomes in patients with oligoprogression following 1st line IO or ChemoIO
Blog
Oct 7, 2024, 16:42
Neoadjuvant therapy for resectable pancreatic cancer suggested by Alan Burguete-Torres
Blog
Oct 7, 2024, 16:37
Herbert Loong: The burden of lung cancer respect no borders
Blog
Oct 7, 2024, 16:33
Lika Katselashvili: Developing combination therapies with biologics in TNBC
Insight
Oct 7, 2024, 16:28
Erman Akkus: Neoadjuvant IO in colon/rectal cancers
Insight
Oct 7, 2024, 16:22
Xiuning Le: Mutational characteristics and clinical outcomes for EGFR+ lung adenocarcinoma
Dialogues
Oct 7, 2024, 16:17
ASCO24 Updates: Jessica Paulus on Lung Cancer Diagnosis Trends and COVID-19 Impact
Insight
Oct 7, 2024, 16:16
Joan Brunet: Raising awareness about Birt-Hogg-Dubé Syndrome
Insight
Oct 7, 2024, 16:03
David Gandara: Joel W. Neal on targeted therapies at WCLC24
Dialogues
Oct 7, 2024, 16:01
ASCO24 Updates: Andrea Wilson-Woods: How Blue Faery Is Changing the Fight Against Liver Cancer
Insight
Oct 7, 2024, 15:59
Getting your Integrative Oncology Proposals Funded
Insight
Oct 7, 2024, 15:53
Pembrolizumab vs. Observation in Muscle-Invasive Urothelial Carcinoma